Smilow Cancer Genetics and Prevention Program, Yale New Haven Health, New Haven, Connecticut 06510, USA;
Department of Pediatric and Adolescent Gynecology, National Institutes of Health, Bethesda, Maryland 20892, USA.
Cold Spring Harb Mol Case Stud. 2023 Jul 11;9(3). doi: 10.1101/mcs.a006281. Print 2023 Jun.
Hereditary connective tissue disorders have overlapping phenotypes, particularly in regard to musculoskeletal features. This contributes to the challenge of phenotype-based clinical diagnoses. However, some hereditary connective tissue disorders have distinct cardiovascular manifestations that require early intervention and specific management. Molecular testing has increased the ability to categorize and diagnose distinct hereditary connective tissue disorders. A 42-yr-old female with a clinical diagnosis of Larsen syndrome from birth presented for genetic testing based on her recent diagnosis of premenopausal breast cancer. She had a past medical history of multiple carotid dissections. As she never had confirmatory molecular genetic testing for Larsen syndrome, whole-exome sequencing was utilized to assess both hereditary cancer predisposition syndromes and connective tissue disorders. A homozygous pathogenic variant in the gene was identified associated with kyphoscoliotic Ehlers-Danlos syndrome. We recommend that patients with a clinical diagnosis of Larsen syndrome undergo broad-based molecular sequencing for multiple hereditary connective tissue disorders. Molecular diagnosis is particularly crucial for all individuals who have a history of significant vascular events in the setting of a clinical diagnosis only. Early diagnosis of a hereditary connective tissue disorder with vascular features allows for screening and subsequent prevention of cardiovascular events.
遗传性结缔组织疾病具有重叠的表型,尤其是在肌肉骨骼特征方面。这增加了基于表型的临床诊断的难度。然而,一些遗传性结缔组织疾病具有独特的心血管表现,需要早期干预和特定的管理。分子检测提高了对不同遗传性结缔组织疾病进行分类和诊断的能力。一位 42 岁的女性,自出生起即被临床诊断为 Larsen 综合征,因近期绝经前乳腺癌的诊断而接受基因检测。她曾有多次颈动脉夹层的病史。由于她从未接受过 Larsen 综合征的确认性分子遗传学检测,因此我们使用全外显子组测序来评估遗传性癌症易感性综合征和结缔组织疾病。在 基因中发现了一个纯合的致病性变异,与脊柱后侧凸型 Ehlers-Danlos 综合征相关。我们建议对临床诊断为 Larsen 综合征的患者进行多种遗传性结缔组织疾病的广泛分子测序。对于仅基于临床诊断且有重大血管事件史的所有个体,分子诊断尤为重要。早期诊断具有血管特征的遗传性结缔组织疾病可以进行心血管事件的筛查和后续预防。